Michael D. Hooven, Director at AtriCure, Inc. (ATRC), bought 1,110 shares at $7.36 ($8K) on 2012-09-13, disclosed to the SEC on 2012-09-14.
Open-market purchase of $8k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.36 | 410 | $3K | 36.9% |
| 2 | $7.37 | 700 | $5K | 63.1% |
| Total | $7.37 avg | 1,110 | $8K | 100% |
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |